In the US, Pemoline (pemoline systemic) is a member of the drug class CNS stimulants and is used to treat ADHD and Sexual Dysfunction - SSRI Induced.
US matches:
- Pemoline
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06BA05
CAS registry number (Chemical Abstracts Service)
0002152-34-3
Chemical Formula
C9-H8-N2-O2
Molecular Weight
176
Therapeutic Category
Central stimulant
Chemical Name
4(5H)-Oxazolone, 2-amino-5-phenyl-
Foreign Names
- Pemolinum (Latin)
- Pemolin (German)
- Pémoline (French)
- Pemolina (Spanish)
Generic Names
- Pemolina (OS: DCIT)
- Pemoline (OS: USAN, JAN, BAN)
- Pémoline (OS: DCF)
- LA 956 (IS)
- Phenylisohydantoine (IS)
- Phenylpseudohydantoine (IS)
- PIO (IS: USA hum. AHFS)
Brand Names
- Betanamin
Sanwa Kagaku, Japan - Ceractiv
Andromaco, Chile - Cylert
Abbott, Israel - Nitan
Rekah, Israel
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.